2018年2月14日上午，87978797威尼斯老品牌院长、国家新药筛选中心主任兼国家化合物样品库主任王明伟研究员在位于美国加州Santa Clara市的安捷伦技术公司总部会晤了生命科学与应用市场部总裁Patrick Kaltenbach先生和安捷伦科技（中国）有限公司大中华区学术科研、临床和战略项目总经理赵影女士。双方在取名为“DNA”的总裁会议室进行了热烈的讨论，就积极参加上海具有全球影响力科创中心建设，在张江高科技园区合作成立卓越技术中心的意向达成一致。会谈前后，王明伟研究员分别参观了安捷伦技术公司的历史陈列室和研究开发设施。
Dr. M.-W. Wang meets Agilent’s Life Sciences Group President P. Kaltenbach at California
In the morning of February 14, 2018, Dr. Ming-Wei Wang, Director of the National Center for Drug Screening/Chinese National Compound Library and Dean of School of Pharmacy, Fudan University met with Mr. Patrick Kaltenbach, President of Life Sciences & Applied Markets Group, Agilent Technologies, Inc. and Madam Ying Chow, Great China Sales Development & Strategic Program Manager of Agilent Technologies (China) Co., Ltd., at Agilent’s headquarters located in Santa Clara, California (U.A.S.). The enthusiastic discussion was conducted in the president’s conference room entitled ‘DNA’, where both parties agreed on the intent of jointly establishing a center of technology excellence in Zhangjiang High-Tech Park, in order to actively participate in Shanghai’s construction of a science and technology innovation center with global impact. Dr. Wang visited Agilent’s history exhibition room and R&D facility, respectively, before and after the above meeting.
